Cooper Net Cash Flow 2010-2025 | COO
Cooper annual/quarterly net cash flow history and growth rate from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
- Cooper net cash flow for the quarter ending April 30, 2025 was $9M, a 202.41% decline year-over-year.
- Cooper net cash flow for the twelve months ending April 30, 2025 was $-0.023B, a 31.19% decline year-over-year.
- Cooper annual net cash flow for 2024 was $-0.013B, a 25.42% decline from 2023.
- Cooper annual net cash flow for 2023 was $-0.018B, a 142.14% decline from 2022.
- Cooper annual net cash flow for 2022 was $0.042B, a 307.92% decline from 2021.
Cooper Annual Net Cash Flow
(Millions of US $) |
| 2024 |
$-13 |
| 2023 |
$-18 |
| 2022 |
$42 |
| 2021 |
$-20 |
| 2020 |
$27 |
| 2019 |
$9 |
| 2018 |
$-9 |
| 2017 |
$-12 |
| 2016 |
$84 |
| 2015 |
$-9 |
| 2014 |
$-52 |
| 2013 |
$65 |
| 2012 |
$8 |
| 2011 |
$2 |
| 2010 |
$0 |
| 2009 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$15.043B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
